New regulatory developments in both the US and Europe are promoting a radical change to accelerate the approval of new medications for rare disease. These include the 21st Century Cure Act in the US and the Adaptive Regulatory Pathway in Europe.
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.
